OMER Q4 2019 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$33M+51.8% YoY

Gross Profit

$33M98.8% margin

Operating Income

-$24M-70.9% margin

Net Income

-$29M-87.5% margin

EPS (Diluted)

$-0.58

QoQ Revenue Growth

+11.9%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$137M

Total Liabilities

$246M

Stockholders' Equity

-$109M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$22M	+51.8%
Gross Profit	$33M	$22M	+51.0%
Operating Income	-$24M	-$18M	-28.3%
Net Income	-$29M	-$24M	-24.2%